CB2 cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: Role of CB2 receptor in pain

@article{Pldy2008CB2CR,
  title={CB2 cannabinoid receptor antagonist SR144528 decreases mu-opioid receptor expression and activation in mouse brainstem: Role of CB2 receptor in pain},
  author={Eszter P{\'a}ldy and Erika Bereczki and M. Lakshmi Santha and Tibor Wenger and Anna Borsodi and Andreas Zimmer and S{\'a}ndor Benyhe},
  journal={Neurochemistry International},
  year={2008},
  volume={53},
  pages={309-316}
}

Figures and Tables from this paper

CNS Effects of CB 2 Cannabinoid Receptors
TLDR
The data and those of others reveal that CB2-Rs are expressed in neurons in the brain and play a role in depression and substance abuse beyond neuro-immuno-cannabinoid activity.
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity
TLDR
Current understanding of CNR2 genomic structure, its polymorphic nature, subtype specificity, from mice to human subjects, and its variants that confer vulnerabilities to neuropsychiatric disorders beyond neuro-immuno-cannabinoid activity are summarized.
CNS Effects of CB2 Cannabinoid Receptors
TLDR
The data and those of others reveal that CB2-Rs are expressed in neurons in the brain and play a role in depression and substance abuse beyond neuro-immuno-cannabinoid activity.
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating &mgr;-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats
TLDR
It is indicated that IT injection of a nonanalgetic dose of a CB2 receptor agonist increased the analgesia effect and alleviated tolerance to morphine in tumor-bearing rats, potentially by regulating MOR expression in the spinal cord and DRG.
Attenuation of morphine antinociceptive tolerance by cannabinoid CB1 and CB2 receptor antagonists
TLDR
It is observed that co-injection of AM251 and JTE907 with morphine attenuated expression of tolerance to morphine analgesic effects and decreased the morphine analgesia.
...
...

References

SHOWING 1-10 OF 66 REFERENCES
CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids.
  • M. Ibrahim, F. Porreca, T. Malan
  • Biology, Medicine
    Proceedings of the National Academy of Sciences of the United States of America
  • 2005
TLDR
Test the hypothesis that CB(2) receptor activation stimulates release from keratinocytes of the endogenous opioid beta-endorphin, which then acts at local neuronal mu-opioid receptors to inhibit nociception and indicates anatomical specificity of opioid effects.
CB2 cannabinoid receptor mediation of antinociception.
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS
  • M. Ibrahim, H. Deng, T. Malan
  • Biology, Medicine
    Proceedings of the National Academy of Sciences of the United States of America
  • 2003
TLDR
AM1241 dose-dependently reversed tactile and thermal hypersensitivity produced by ligation of the L5 and L6 spinal nerves in rats, demonstrating a mechanism leading to the inhibition of pain, one that targets receptors localized exclusively outside the CNS.
Noladin ether, a putative endocannabinoid, inhibits μ-opioid receptor activation via CB2 cannabinoid receptors
Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats
TLDR
At the level of the spinal cord, CB2 receptors have inhibitory effects in neuropathic, but not sham‐operated rats suggesting that spinal CB2 may be an important analgesic target.
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor.
A Molecular Basis of Analgesic Tolerance to Cannabinoids
TLDR
It is shown that the type 1 cannabinoid receptor (CB1) interacts physically with G-protein-associated sorting protein 1 (GASP1), a protein that sorts receptors in lysosomal compartments destined for degradation, which suggests that GASP 1 is a key regulator of the fate of CB1 after agonist exposure in the nervous system and critically determines analgesic tolerance to cannabinoids.
...
...